IPSEY:OTCMKTS
Ipsen
US$ 41,90
0,00%
(0,00) 1D
30 sep, 14:57:29 GMT-4 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor IPSEY genereren…
Beursw.
11,77 mld.
Gem. vol.
518,00
Volume
327,00
52 wk hoog
US$ 51,10
52 wk laag
US$ 32,68
Bèta
0,41
Uitstaande aandelen
335,26 mln.
Aantal medewerkers
6K
Beursw.
11,77 mld.
Gem. vol.
518,00
Volume
327,00
52 wk hoog
US$ 51,10
52 wk laag
US$ 32,68
Bèta
0,41
Uitstaande aandelen
335,26 mln.
Aantal medewerkers
6K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Yahoo Finance UK
·
3 dagen geleden
GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update
Profiel
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
Over Ipsen